• Facebook
  • Twitter
  • SP_SOCIAL_INSTAGRAM
  • YouTube
  • Linkedin
  • This email address is being protected from spambots. You need JavaScript enabled to view it.
The Aurum InstituteThe Aurum InstituteThe Aurum Institute
  • Home
  • About Us
    • About Us
      • Who We Are
      • Our History
      • Global Footprint
      • Careers
      • Our Partners
      • Contact Us
    • Governance
      • Board of Directors
      • Group Executive Management
      • South Africa Executive Management
      • International Management
  • What We Do
    • What We Do
      • Clinical Research Division
      • Implementation Research Division
      • Health Programmes
      • COVID-19
      • POP INN
    • Aurum International
      • Global Projects
      • Aurum Institute Ghana
      • Aurum Mozambique
  • Area of Expertise
    • Tuberculosis
    • HIV
    • Health Systems
    • Key Populations
    • COVID-19
  • Affiliates
    • CHAPS
    • IMPAACT4TB
    • INNOVA
    • Youth Health Africa
    • ASHA
    • GHI
  • Library
    • Resources
    • Publications
    • Annual Reports
    • Annual Financials
  • News & Updates
    • News
      • Latest News
      • Press Releases
      • Aurum in the News
    • Multimedia
      • Image Gallery
      • Multimedia
  • Improving availability of patient-friendly tuberculosis preventive therapy

    Global partners working to tackle the tuberculosis (TB) epidemic have announced the latest in a package of measures to increase supply security and availability of a short-course TB preventive therapy...
  • Shorter weekly course of rifapentine-isoniazid associated with much higher treatment completion rates compared to longer daily course

    A randomized trial found that treatment completion was higher among HIV-positive persons who were assigned a shorter course of rifapentine-isoniazid therapy to prevent tuberculosis disease compared to...
  • IMPAACT4TB Project statement responding to the WHO Global TB Report 2021

     IMPAACT4TB Welcomes Gains in TB Prevention Among People Living With HIV, But Calls for Urgent Action to Address TB Prevention Deficits Among Children and Household Contacts of People Affected by TB ...
  • IAVI and Moderna launch first-in-Africa clinical trial of mRNA HIV vaccine development program

    Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity NEW YORK, NY AND CAMBRIDGE, MA — MAY 18,...
  • Aurum Institute Ghana: Making significant contributions towards Ghana’s healthcare services.

    Aurum Institute Ghana, a proudly African organisation working to advance health science and innovation has reached a milestone of five years of operation in Ghana.   Aurum Ghana is part of T...

Popular Tags

AurumNews 118 Tuberculosis 95 International 69 Public Health 63 COVID-19 56 Clinical Research 50 Implementation Research 45 HIV 42 Impaact4tb 41 Aurum Ghana 40 Unitaid 24 Aurum Mozambique 23

Most Read

  • ="Aurum Aurum staff appointed to Vanderbilt University
  • ="Aurum Aurum delivers life-saving medication to homes
  • ="World World Pharmacy Month: Aurum celebrates its pharmacists
  • ="Celebrating Celebrating all women at POP INN

Recent Posts

Aurum tackles TB in Western Cape farmlands Aurum tackles TB in Western Cape farmlands
Aurum Annual Report 2021 Aurum Annual Report 2021
Aurum Institute Ghana: Making significant contributions towards Ghana’s healthcare services.  Aurum Institute Ghana: Making significant contributions towards Ghana’s healthcare services.
Building partnerships of consequence beyond project funding Building partnerships of consequence beyond project funding

About Us

Who We Are

History

Global Footprint

Board of Directors

Careers

Contact Us

What We do

Clinical Research Division

Implementation Research Division

Health Programme

HIV

Tuberculosis

Aurum International

International Division

Aurum Ghana

Aurum Mozambique

Menu Image

Head Office

29 Queens Road,
Parktown, Johannesburg,
South Africa, 2193.

(+27) 10 590 1300

info@auruminstitute.org

Amazon SmileTechSoup TechSoup

  • Facebook
  • Twitter
  • SP_SOCIAL_INSTAGRAM
  • YouTube
  • Linkedin
© 2022 The Aurum Institute. All Rights Reserved.

Website Disclaimer | Privacy Policy | PAIA Manual | PLGHA Policy | Conflict of Interest

  • Home
  • About Us
    • About Us
      • Who We Are
      • Our History
      • Global Footprint
      • Careers
      • Our Partners
      • Contact Us
    • Governance
      • Board of Directors
      • Group Executive Management
      • South Africa Executive Management
      • International Management
  • What We Do
    • What We Do
      • Clinical Research Division
      • Implementation Research Division
      • Health Programmes
      • COVID-19
      • POP INN
    • Aurum International
      • Global Projects
      • Aurum Institute Ghana
      • Aurum Mozambique
  • Area of Expertise
    • Tuberculosis
    • HIV
    • Health Systems
    • Key Populations
    • COVID-19
  • Affiliates
    • CHAPS
    • IMPAACT4TB
    • INNOVA
    • Youth Health Africa
    • ASHA
    • GHI
  • Library
    • Resources
    • Publications
    • Annual Reports
    • Annual Financials
  • News & Updates
    • News
      • Latest News
      • Press Releases
      • Aurum in the News
    • Multimedia
      • Image Gallery
      • Multimedia